Here is a comprehensive summary of the 2025 AHA ACLS Guidelines (published October 2025 in Circulation, Vol. 152, Suppl. 2) - the most current version as of mid-2026.
2025 AHA ACLS Guidelines - Key Updates
The 2025 guidelines represent a full comprehensive revision of all AHA resuscitation guidelines, replacing the 2020 edition. A total of 760 specific recommendations were made, including 233 Class I and 451 Class II recommendations.
1. Unified Chain of Survival
- The 2020 guidelines had four separate chains of survival (adult OHCA, adult IHCA, pediatric OHCA, pediatric IHCA).
- 2025 change: A single, unified Chain of Survival framework now applies to all ages and settings (OHCA and IHCA combined).
- Each link now has a dedicated visual symbol; the symbol for high-quality CPR now includes lungs alongside chest compressions, reinforcing the role of breaths, particularly in pediatric and opioid-related arrests.
2. High-Quality CPR - Core Parameters (Unchanged but Reinforced)
| Parameter | Target |
|---|
| Compression rate | 100-120/min |
| Compression depth (adults) | 5-6 cm (2-2.4 in) |
| Chest recoil | Full recoil between compressions |
| Compression fraction | >60% (minimize pauses to <10 seconds) |
| Compression:ventilation ratio | 30:2 (without advanced airway) |
| With advanced airway | Continuous compressions at 100-120/min, 1 breath every 6 sec |
3. Defibrillation - New Recommendations
- Standard defibrillation: Early defibrillation remains top priority for shockable rhythms (VF/pVT). Start at 200 J biphasic (or max energy).
- Double Sequential Defibrillation (DSED): The 2025 guidelines state the usefulness of DSED for adults with persistent VF/pVT after 3 or more consecutive shocks has not been established - this is an important update given the DOSE VF trial.
- Vector Change Defibrillation (VCD): A new 2025 recommendation - usefulness of vector change defibrillation for refractory VF/pVT also has not been established (new literature added this as a distinct consideration).
- Resume CPR immediately after each shock, even if ROSC appears to occur.
4. Pharmacology - Updated Guidance
Epinephrine
- Shockable rhythms (VF/pVT): Give epinephrine after the first failed defibrillation attempt, then every 3-5 minutes.
- Non-shockable rhythms (PEA/asystole): Administer epinephrine as early as possible - 2025 explicitly labels early timing as critical (the 2020 guideline did not emphasize this as strongly).
- Dose: 1 mg IV/IO every 3-5 minutes (unchanged).
Antiarrhythmics
- Amiodarone or lidocaine for shock-refractory VF/pVT - used after failed shocks + epinephrine.
- Amiodarone dose: 300 mg IV/IO first dose, then 150 mg if needed.
- Lidocaine alternative: 1-1.5 mg/kg IV/IO.
- Vasopressin has been removed from the cardiac arrest algorithm in prior updates and this remains in 2025.
Opioid-Related Cardiac Arrest
- Expanded emphasis on rapid naloxone administration.
- New recommendation for public access to opioid emergency kits.
5. Airway Management
- No single airway modality is superior: BVM, supraglottic airway (SGA), and endotracheal intubation (ETI) are all acceptable during CPR - evidence shows similar patient outcomes.
- Do not interrupt compressions to place an airway.
- Once advanced airway is in place: continuous compressions + 1 breath every 6 seconds (10 breaths/min).
- Waveform capnography (EtCO2) now plays a central role in monitoring CPR quality - low EtCO2 signals poor compressions or prolonged arrest; target EtCO2 >10-20 mmHg during resuscitation.
- Do not use EtCO2 alone to terminate resuscitation (2025 explicit caution).
6. Monitoring During CPR
- EtCO2 monitoring recommended throughout.
- Arterial diastolic pressure monitoring (when arterial line available): target ≥25 mmHg (infants), ≥30 mmHg (children).
- Point-of-care ultrasound (POCUS): now has explicit guideline support for use in ALS to identify reversible causes.
7. Reversible Causes - The 5 H's and 5 T's
Remains a cornerstone. Search for and treat:
5 H's: Hypovolemia, Hypoxia, Hydrogen ion (acidosis), Hypo/hyperkalemia, Hypothermia
5 T's: Tension pneumothorax, Tamponade (cardiac), Thrombosis (coronary - ACS), Thrombosis (pulmonary - PE), Toxins/"Tablets"
8. Post-Cardiac Arrest Care (ROSC)
Updated bundles include:
- Targeted temperature management (TTM): Preventing fever (>37.7°C) remains recommended. The benefit of active cooling to 32-36°C is less certain after the TTM2 trial - 2025 guidelines reflect this uncertainty.
- Coronary angiography: No longer routinely recommended immediately post-arrest without ST-elevation - selective approach based on clinical features.
- Hemodynamic optimization: Target MAP ≥65 mmHg, avoid hypoxia and hypocapnia.
- Neuroprognostication: Multimodal approach; do not make decisions earlier than 72 hours post-ROSC.
9. Team Dynamics and Human Factors
A standout new emphasis in 2025:
- Stronger focus on closed-loop communication.
- Enhanced guidance for the team leader role.
- Clinical debriefing: Both immediate ("hot") and delayed ("cold") debriefing after CPR events is now explicitly recommended.
- New recommendations on resuscitation team composition (in-hospital and out-of-hospital).
10. Terminology Updates
- "Rescue breaths" is no longer used - replaced with "breaths" (for assisted breathing during CPR).
- "Ventilation" is reserved for mechanical respiratory support by professionals.
ACLS Universal Algorithm Overview
The classic Primary-Secondary Survey approach remains the structural framework:
Universal ACLS Algorithm - Tintinalli's Emergency Medicine
Key References
- The full 2025 Adult ALS guidelines: Wigginton et al., Circulation 2025, PMID 41122884 (Part 9 of the 2025 AHA CPR/ECC guidelines)
- AHA 2025 Guidelines Highlights PDF - concise summary from the AHA
- Tintinalli's Emergency Medicine: A Comprehensive Study Guide, Chapter 24 (ACLS framework)